5 May 2020 in Human Mutation
14 April 2020 in Clinical Endocrinology
15 November 2024 in medRxiv
The gene CYP21A2, mapped to the RCCX module in 6p21.3, is responsible for the 21-hydroxylase deficiency (21OHD). In this work, we used Oxford Nanopore Technology (ONT) Long Reads (LR) sequencing to analyze samples from a large Argentinian cohort of 21OHD. Our goal was to gain additional information about the GVs involved in the rearrangements, to obtain higher resolution for the breakpoints of converted alleles and to retrieve new data of TNX and CYP21A1P genes. A total of 34 samples were sequenced in 2 amplicons of 8.5 Kb covering the centromeric and telomeric RCCX modules. The number of GVs found varied between 17-106 and all expected pathogenic GVs and new ones were obtained with the LR sequencing workflow developed. From the 21 alleles with macroconverted or chimeric genes containing the promoter of the CYP21A1P, we uncovered 5 of them lacking GVs commonly expected to be involved in 21OHD rearrangements. Importantly, we reclassified one patient with a deletion that had been overlooked with the current diagnostic technologies applied. These new findings change the genetic counseling for the patient and his family related to the presence of a carrier allele for Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome (CAH-X). Furthermore, by addressing the study of the centromeric and the telomeric RCCX modules, we found 19 GVs for CYP21A1P and 29 GVs for TNXA not previously described in Latin American populations or not reported in any of the consulted databases. This study may represent the first one applying ONT LR in clinical studies in Latin America, highlighting the importance of LR sequencing as a high-resolution method of diagnosis and better cost-effective balance. It allows us to better understand the diversity of the RCCX modules and to gain knowledge of the molecular pathogenesis of the disease.
7 July 2013 in Case Reports in Genetics
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency accounts for 90%–95% of cases. This autosomal recessive disorder has a broad spectrum of clinical forms, ranging from severe or classical, which includes the salt-wasting and simple virilizing forms, to the mild late onset or nonclassical form. Most of the disease-causing mutations described are likely to be the consequence of nonhomologous recombination or gene conversion events between the activeCYP21A2gene and its homologous CYP21A1P pseudogene. Nevertheless, an increasing number of naturally occurring mutations have been found. The change p.H62L is one of the most frequent rare mutations of theCYP21A2gene. It was suggested that the p.H62L represents a mild mutation that may be responsible for a more severe enzymatic impairment when presented with another mild mutation on the same allele. In this report, a 20-year-old woman carrying an isolated p.H62L mutation in compound heterozygosity with c.283-13A/C>G mutation is described. Although a mildly nonclassical phenotype was expected, clinical signs and hormonal profile of the patient are consistent with a more severe simple virilizing form of 21-hydroxylase deficiency. The study of genotype-phenotype correlation in additional patients would help in defining the role of p.H62L in disease manifestation.